Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor
β Scribed by Takashi Nishimura; Kazuhito Watanabe; Ushaku Lee; Takashi Yahata; Kiyoshi Ando; Minoru Kimura; Yoshitaka Hiroyama; Michiko Kobayashi; Steven H. Herrmann; Sonoko Habu
- Book ID
- 107908595
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 375 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0165-2478
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Interleukin 12 (IL-12) exhibits anti-tumor activity in a variety of laboratory models. Although IL-12 itself activates strong anti-tumor activity, the combination of vaccine therapy with IL-2-transduced tumor cells and systemic rIL-12 has been shown to cure tumor-bearing mice more effectively than e
## Abstract The antitumor activity of highly purified tumor necrosis factor (TNF) was tested against eight kinds of murine tumor and five kinds of human tumor heterotransplanted into nude mice. Mice were treated by intravenous or intratumoral injection of TNF, commencing when the tumors were well e
## Abstract Targeting cytotoxins or immunotoxins to tumor cell surface receptors represents a new approach for the treatment of cancers. We tested the antitumor activity of a cytotoxin (ILβ4βPE) composed of an interleukinβ4 (ILβ4) targeting moiety and a truncated form of __Pseudomonas__ exotoxin A